CD137-positive cells were slightly larger than CD137-negative CLL cells as judged by FSC intensity, and expressed CD54 and CD95 at higher levels (Fig. 2C), suggesting that they might have recently been activated. The gene discussed is TNFRSF9; the disease is B-cell chronic lymphocytic leukemia.